
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>AS-OCT for use in uveitis.</title>
<link>https://www.opsweb.org/forums/posts.aspx?topic=377378</link>
<description></description>
<lastBuildDate>Sun, 19 Jul 2026 04:08:55 GMT</lastBuildDate>
<pubDate>Tue, 20 Mar 2012 15:16:48 GMT</pubDate>
<copyright>Copyright &#xA9; 2012 Ophthalmic Photographers&apos; Society</copyright>
<atom:link href="https://www.opsweb.org/forums/topic_rss.asp?id=377378" rel="self" type="application/rss+xml"></atom:link>
<item>
<title>AS-OCT for use in uveitis.</title>
<link>https://www.opsweb.org/forums/posts.aspx?topic=377378</link>
<guid>https://www.opsweb.org/forums/posts.aspx?topic=377378</guid>
<description><![CDATA[Is anyone using anterior segment OCT to evaluate the AC in uveitis for early signs of cell/flare?...or to evaluate the AC in the presence of corneal edema that prevents visualization through it? &nbsp; &nbsp;]]></description>
<pubDate>Sun, 4 Mar 2012 22:45:43 GMT</pubDate>
</item>
<item>
<title></title>
<link>https://www.opsweb.org/forums/posts.aspx?topic=387461</link>
<guid>https://www.opsweb.org/forums/posts.aspx?topic=387461</guid>
<description><![CDATA[<p>Mike- &nbsp;We aren't using AS-OCT to look for cell and flare, but I used AS-OCT for other reasons and have seen it. &nbsp;I imagine you could do this. &nbsp;As far as checking out the AC when there's corneal edema, it is still an OCT technology so anterior thickness will block posterior pathology. &nbsp;I'd give it a try though to see if the edema is strong enough to block this. &nbsp;Let us know how it turns out. &nbsp;Post a picture or two!</p><p><br></p>]]></description>
<pubDate>Tue, 20 Mar 2012 15:04:24 GMT</pubDate>
</item>
<item>
<title></title>
<link>https://www.opsweb.org/forums/posts.aspx?topic=387534</link>
<guid>https://www.opsweb.org/forums/posts.aspx?topic=387534</guid>
<description><![CDATA[<P>Mike,</P>
<P>We have looked at some uveitis patients with the Visante, and my opinion is that I see more on the UBM than the OCT. I do look forward to using the spectral domain OCTs to see if they pick up more of the cells, but have not had a patient to try it on... </P>
<P>Libba Affel</P>]]></description>
<pubDate>Tue, 20 Mar 2012 16:16:48 GMT</pubDate>
</item>
</channel>
</rss>
